Concepedia

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function

Wendy E. Boertien, Esther Meijer, Paul E. de Jong, Gert J. Ter Horst, Remco J. Renken, Eric J. van der Jagt, Peter Kappert, John Ouyang, Gerwin E. Engels, Willem van Oeveren,

American Journal of Kidney Diseases · 2015 · 79 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

Andrew S. Levey, Josef Coresh, Tom Greene et al. · Annals of Internal Medicine · 2006 · 5.8K citations

, , +17

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2012 · 1.6K citations · Full text

, , +14

Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin

Nils G. Morgenthaler, Joachim Struck, Christine Alonso et al. · Clinical Chemistry · 2005 · 1.2K citations · Full text

, , +17

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

Vincent H. Gattone, Xiaofang Wang, Peter C. Harris et al. · Nature Medicine · 2003 · 669 citations

, , +8

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1

David Ravine, LJ Sheffield, D. M. Danks et al. · The Lancet · 1994 · 565 citations

, , +12